Comparison of the therapeutic effect of the Persian Medicine Protocol with the common treatment of chronic rhinosinusitis
A randomized clinical trial
Keywords:
Rhinosinusitis, Persian medicine, Origanum, Lavender, LicoriceAbstract
Background: Chronic rhinosinusitis is one of the most common diseases affecting the quality of life of patients. Patients suffer from high costs in the diagnosis and treatment of the disease. Frequent recurrence and failure of therapeutic protocols are among the most important issues in the management of this disease. In view of this, the use of traditional and complementary therapies to promote the treatment of this disease has been increasingly taken into account. Objective: Comparison of the effectiveness of the Persian Medicine Protocol with the conventional therapy in the treatment of chronic rhinosinusitis. Methods: A randomized clinical trial was conducted at Imam Reza Hospital in Mashhad, Iran from July 2016 to March 2017. For patients with chronic rhinosinusitis symptoms, endoscopy of the sinuses was performed by an ENT specialist and in the case of negative endoscopy, paranasal sinus CT scan was requested. A total of 42 patients with chronic rhinosinusitis were randomly assigned to two groups. The first group (classical) received systemic and intranasal cortisone, and the second group (traditional) received a therapeutic Persian medicine protocol including intranasal lavender oil, and Liquorice Marjoram Tea (L. M. tea) for six weeks. The symptoms of the patients were evaluated using the SNOT-22 questionnaire at the beginning of the study and at the sixth week. If no improvement occurs, treatment continued for 12 weeks. Data were analyzed by SPSS version 16, using ANOVA, independent-samples and paired-samples t-test, Wilcoxon signed-rank test, and simple linear regression. Results: In 20 patients in the traditional group, the decrease in SNOT score was observed as 56% after 6 weeks treatment (p=0.001), which is similar to the effect of the first group (classical). Although there was no statically significant difference between the two groups, in clinical terms, the difference in mean systemic symptoms such as confusion with 1.05 (p=0.5) and fatigue with 1.63 (p=0.01) had more improvement in the traditional group, and the difference in mean local symptoms such as nasal congestion with 2.37 (p=0.78) and runny nose with 1.95 (p=0.14) had a more decrease in the classical group. Conclusion: The results of this trial indicate the effectiveness of the Persian Medicine Protocol (including Lavender oil and L.M tea) in the treatment of chronic rhinosinusitis, especially on improving systemic symptoms. Nevertheless more clinical studies are necessary to support the acquired results. Trial registration: This trial was registered at the Iranian Center for Clinical Trials (ID: IRCT2015112425217N1). Funding: This research is part of a PhD thesis and is funded by the Vice-Chancellor for Research at Mashhad University of Medical Sciences, Grant No. 931673.References
Fauci A, Braunwald E, Kasper D, Hauser S, Longo D, Jameson J, et al. Harrison's Principles of Internal
Medicine. 17th Edition: Mcgraw-hill; 2008
Oxford LE, McClay J. Complications of acute sinusitis in children. Otolaryngology-Head and Neck
Surgery. 2005; 133(1): 32-7. doi: 10.1016/j.otohns.2005.03.020. PMID: 16025049.
Durr DG, Desrosiers MY, Dassa C. Impact of rhinosinusitis in health care delivery: the Quebec experience.
The Journal of otolaryngology. 2001; 30(2): 93-7. PMID: 11770963
Benninger MS, Ferguson BJ, Hadley JA, Hamilos DL, Jacobs M, Kennedy DW, et al. Otolaryngology - Head and Neck Surgery. 2003; 129(3, Supplement): S1-32.
Andy SA, Sarookhani D, Tavirany MR. Prevalence of Sinusitis in Iran: a systematic review and meta- analysis study. Der Pharmacia Lettre. 2016; 8(5): 31-9.
Safari M, Mohebbi N. Assessment of the prevalence of sinusitis in children under the age of 12 years with
asthma in Hamedan. The Iranian Journal of Otorhinolaryngology. 2010; 21(3): 133-8.
Ehsanipour F, Javaher Tarash N, Pirdehghan A. The Prevalence of Sinusitis in Young Asthmatic
Patients(2-16y) Referred to Rasoul-e-Akram Hospital During 1993-2003. RJMS. 2005; 12(45): 31-6.
Gliklich RE, Metson R. The health impact of chronic sinusitis in patients seeking otolaryngologic care.
Otolaryngology-Head and Neck Surgery. 1995; 113(1): 104-9. doi: 10.1016/S0194-5998(95)70152-4.
Goetzel RZ, Hawkins K, Ozminkowski RJ, Wang S. The health and productivity cost burden of the" top
" physical and mental health conditions affecting six large US employers in 1999. Journal of
occupational and environmental medicine. 2003; 45(1): 5-14. doi: 10.1097/00043764-200301000-00007.
PMID: 12553174.
Anand VK. Epidemiology and economic impact of rhinosinusitis. Annals Of Otology Rhinology And
Laryngology. 2004; 113(5): 3-5. doi: 10.1177/00034894041130S502. PMID: 15174752.
Chung SD, Hung SH, Lin HC, Lin CC. Health care service utilization among patients with chronic
rhinosinusitis: a population-based study. The Laryngoscope. 2014; 124(6): 1285-9. doi:
1002/lary.24500. PMID: 24338913
Van Crombruggen K, Zhang N, Gevaert P, Tomassen P, Bachert C. Pathogenesis of chronic rhinosinusitis:
inflammation. J Allergy Clin Immunol. 2011; 128(4): 728-32. doi: 10.1016/j.jaci.2011.07.049. PMID:
Fokkens WJ, Lund VJ, Mullol J, Bachert C, Alobid I, Baroody F, et al. EPOS 2012: European position
paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists. Rhinology. 2012;
(1): 1-12. doi: 10.4193/Rhino50E2. PMID: 22469599.
Probst R, Grevers G. Basic Otorhinolaryngology: A Step-by-Step Learning Guide: Thieme; 2011.
Wynn R, Har‐El G. Recurrence rates after endoscopic sinus surgery for massive sinus polyposis. The
Laryngoscope. 2004; 114(5): 811-3. doi: 10.1097/00005537-200405000-00004. PMID: 15126735.
Rotenberg BW, Bertens KA. Use of complementary and alternative medical therapies for chronic
rhinosinusitis: a canadian perspective. J Otolaryngol Head Neck Surg. 2010; 39(5): 586-93. PMID:
Hatipoğlu U, Rubinstein I. Anti-inflammatory treatment of chronic rhinosinusitis: a shifting paradigm.
Current allergy and asthma reports. 2008; 8(2): 154-61. doi: 10.1007/s11882-008-0026-6. PMID:
Hozni S, Azmiyan Moghadam F, Yeganeh M, Haghshenas S. Evaluation of Demographic Characteristics
and Attitudes about Traditional Medicine among Patients Refered to a Clinic. Journal of Guilan University
of Medical Sciences. 2015; 24(94): 72-9.
Guo R, Canter PH, Ernst E. Herbal medicines for the treatment of rhinosinusitis: a systematic review.
Otolaryngology-Head and Neck Surgery. 2006; 135(4): 496-506. doi: 10.1016/j.otohns.2006.06.1254.
PMID: 17011407.
Ghazi-Moghadam K, Inançlı HM, Bazazy N, Plinkert PK, Efferth T, Sertel S. Phytomedicine in
Otorhinolaryngology and Pulmonology: Clinical Trials with Herbal Remedies. Pharmaceuticals. 2012;
(8): 853-74. doi: 10.3390/ph5080853. PMID: 24280678, PMCID: PMC3763668.
Chitsaz M, Mohammadi H, N M, Kamalinejad CE, and others. Anti-bacterial effects of the plant Polk
(Stachys schtschegleevii) in vitro (2007); Bimonthly Journal of Shahed University, Issue 67
Süleyman H, Demirezer LÖ, Kuruüzüm A, Banoğlu Z, Göçer F, Özbakir G, et al. Antiinflammatory effect
of the aqueous extract from Rumex patientia roots. Journal of ethnopharmacology. 1999; 65(2): 141-8. doi:
1016/S0378-8741(98)00175-5.
Elahi H, Masroorchehr MR, Nemati S, Kamalinejad M, Besharat M, Hajimehdipoor H, et al. Historical
Applications of Nigella sativa L.(Black cumin) in the Treatment of Zokam and Nazleh in Persian Medicine.
Journal of Research on History of Medicine. 2014; 3(1): 11-20.
Avicenna H. Ghanoon fe teb. Beirut: Aljoze Sales. Darolhaya Altras Alarabi. 2004: 413.
Aghili Khorasani MH. Gharabadin e kabir (persian). Qom: Noor e vahy; 2011: 954.
Jalessi M, Farhadi M, Kamrava SK, Amintehran E, Asghari A, Rezaei Hemami M, et al. The Reliability
and Validity of the Persian Version of Sinonasal Outcome Test 22 (Snot 22) Questionnaires. Iranian Red
Crescent Medical Journal. 2013; 15(5): 404-8 doi: 10.5812/ircmj.7937. PMID: 24349728, PMCID:
PMC3838650.
Madani S, Kousarian M, Khalilian A, Rabiei K, Azadbakht M. Origanum Vulgar Inhaler in The Treatment
of Chronic Rhinosinositis, A Double Blind Placebo Controlled Randomized Clinical Trial. Journal of
Mazandaran University of Medical Sciences. 2007.
Neher A, Gstottner M, Thaurer M, Augustijns P, Reinelt M, Schobersberger W. Influence of essential and
fatty oils on ciliary beat frequency of human nasal epithelial cells. American journal of rhinology. 2008;
(2): 130-4. PMID: 18416967.
Giovannini D, Gismondi A, Basso A, Canuti L, Braglia R, Canini A, et al. Lavandula angustifolia Mill.
Essential Oil Exerts Antibacterial and Anti-Inflammatory Effect in Macrophage Mediated Immune
Response to Staphylococcus aureus. Immunological investigations. 2016; 45(1): 11-28. PMID: 26730790.
doi: 10.3109/08820139.2015.1085392. PMID: 26730790.
Ozogul Y, Kuley E, Ucar Y, Ozogul F. Antimicrobial Impacts of Essential Oils on Food Borne-Pathogens.
Recent patents on food, nutrition & agriculture. 2015; 7(1): 53-61. doi:
2174/2212798407666150615112153. PMID: 26072990.
Prusinowska R, Smigielski K, Stobiecka A, Kunicka-Styczynska A. Hydrolates from lavender (Lavandula
angustifolia)--their chemical composition as well as aromatic, antimicrobial and antioxidant properties.
Natural product research. 2016; 30(4): 386-93. doi: 10.1080/14786419.2015.1016939. PMID: 25738904.
Georgiev YN, Ognyanov MH, Kiyohara H, Batsalova TG, Dzhambazov BM, Ciz M, et al. Acidic
polysaccharide complexes from purslane, silver linden and lavender stimulate Peyer's patch immune cells
through innate and adaptive mechanisms. International journal of biological macromolecules. 2017; 105(Pt
: 730-40. doi: 10.1016/j.ijbiomac.2017.07.095. PMID: 28732735.
Gostner JM, Ganzera M, Becker K, Geisler S, Schroecksnadel S, Uberall F, et al. Lavender oil suppresses
indoleamine 2,3-dioxygenase activity in human PBMC. BMC complementary and alternative medicine.
; 14: 503. PMID: 25515049, PMCID: PMC4301885.
Kiecolt-Glaser JK, Graham JE, Malarkey WB, Porter K, Lemeshow S, Glaser R. Olfactory influences on
mood and autonomic, endocrine, and immune function. Psychoneuroendocrinology. 2008; 33(3): 328-39.
PMID: 18178322, PMCID: PMC2278291.
Trellakis S, Fischer C, Rydleuskaya A, Tagay S, Bruderek K, Greve J, et al. Subconscious olfactory
influences of stimulant and relaxant odors on immune function. Eur Arch Otorhinolaryngol. 2012; 269(8):
-16. doi: 10.1007/s00405-011-1876-4. PMID: 22159968.
de la Puerta R, Martinez-Dominguez E, Ruiz-Gutierrez V. Effect of minor components of virgin olive oil
on topical antiinflammatory assays. Zeitschrift fur Naturforschung C. 2000; 55(9-10): 814-9. PMID:
Liu Y, McKeever LC, Malik NS. Assessment of the Antimicrobial Activity of Olive Leaf Extract Against
Foodborne Bacterial Pathogens. Frontiers in microbiology. 2017; 8: 113. PMID: 28210244, PMCID:
PMC5288333.
Aparicio-Soto M, Sanchez-Hidalgo M, Rosillo MA, Castejon ML, Alarcon-de-la-Lastra C. Extra virgin
olive oil: a key functional food for prevention of immune-inflammatory diseases. Food Funct. 2016; 7(11):
-505. doi: 10.1039/c6fo01094f. PMID: 27783083.
Martin-Pelaez S, Castaner O, Sola R, Motilva MJ, Castell M, Perez-Cano FJ, et al. Influence of Phenol- Enriched Olive Oils on Human Intestinal Immune Function. Nutrients. 2016; 8(4): 213. PMID: 27077879,
PMCID: PMC4848682.
Fito M, Gimeno E, Covas MI, Miro E, Lopez-Sabater Mdel C, Farre M, et al. Postprandial and short-term
effects of dietary virgin olive oil on oxidant/antioxidant status. Lipids. 2002; 37(3): 245-51. PMID:
Incani A, Serra G, Atzeri A, Melis MP, Serreli G, Bandino G, et al. Extra virgin olive oil phenolic extracts
counteract the pro-oxidant effect of dietary oxidized lipids in human intestinal cells. Food Chem Toxicol.
; 90: 171-80. doi: 10.1016/j.fct.2016.02.015. PMID: 26911552.
Katsoulieris EN. The olive leaf extract oleuropein exerts protective effects against oxidant-induced cell
death, concurrently displaying pro-oxidant activity in human hepatocarcinoma cells. Redox Rep. 2016;
(2): 90-7. PMID: 26305493.
Rahmani AH, Albutti AS, Aly SM. Therapeutics role of olive fruits/oil in the prevention of diseases via
modulation of anti-oxidant, anti-tumour and genetic activity. International journal of clinical and
experimental medicine. 2014; 7(4): 799-808. PMID: 24955148, PMCID: PMC4057827.
Schillaci D, Napoli EM, Cusimano MG, Vitale M, Ruberto A. Origanum vulgare subsp. hirtum essential oil
prevented biofilm formation and showed antibacterial activity against planktonic and sessile bacterial cells.
Journal of food protection. 2013; 76(10): 1747-52. PMID: 24112575.
Bharti V, Vasudeva N, Sharma S, Duhan JS. Antibacterial activities of Origanum vulgare alone and in
combination with different antimicrobials against clinical isolates of Salmonella typhi. Ancient science of
life. 2013; 32(4): 212-6. PMID: 25364204, PMCID: PMC4213973.
Saeed S, Tariq P. Antibacterial activity of oregano (Origanum vulgare Linn.) against gram positive
bacteria. Pak J Pharm Sci. 2009; 22(4): 421-4. PMID: 19783523.
Ksouri S, Djebir S, Bentorki AA, Gouri A, Hadef Y, Benakhla A. Antifungal activity of essential oils
extract from Origanum floribundum Munby, Rosmarinus officinalis L. and Thymus ciliatus Desf. against
Candida albicans isolated from bovine clinical mastitis. J Mycol Med. 2017; 27(2): 245-9. doi:
1016/j.mycmed.2017.03.004. PMID: 28454927.
Waller SB, Hoffmann JF, Madrid IM, Picoli T, Cleff MB, Chaves FC, et al. Polar Origanum vulgare
(Lamiaceae) extracts with antifungal potential against Sporothrix brasiliensis. Med Mycol. 2018; 56(2):
-233. doi: 10.1093/mmy/myx031. PMID: 28482071.
Bharti V, Vasudeva N, Kumar S. Anti-oxidant studies and anti-microbial effect of Origanum vulgare Linn
in combination with standard antibiotics. Ayu. 2014; 35(1): 71-8. PMID: 25364204, PMCID:
PMC4213973.
Ashraf A, Ashraf MM, Rafiqe A, Aslam B, Galani S, Zafar S, et al. In vivo antiviral potential of
Glycyrrhiza glabra extract against Newcastle disease virus. Pak J Pharm Sci. 2017; 30(2): 567-72. PMID:
Chakotiya AS, Tanwar A, Srivastava P, Narula A, Sharma RK. Effect of aquo-alchoholic extract of
Glycyrrhiza glabra against Pseudomonas aeruginosa in Mice Lung Infection Model. Biomedicine &
pharmacotherapy. 2017; 90: 171-8. PMID: 28355591.
Sharma H, Yunus GY, Agrawal R, Kalra M, Verma S, Bhattar S. Antifungal efficacy of three medicinal
plants Glycyrrhiza glabra, Ficus religiosa, and Plantago major against oral Candida albicans: A
comparative analysis. Indian journal of dental research. 2016; 27(4): 433-6. PMID: 27723643.
Hejazi, II, Khanam R, Mehdi SH, Bhat AR, Moshahid Alam Rizvi M, Islam A, et al. New insights into the
antioxidant and apoptotic potential of Glycyrrhiza glabra L. during hydrogen peroxide mediated oxidative
stress: An in vitro and in silico evaluation. Biomedicine & pharmacotherapy. 2017; 94: 265-79. PMID:
Franceschelli S, Pesce M, Vinciguerra I, Ferrone A, Riccioni G, Patruno A, et al. Licocalchone-C extracted
from Glycyrrhiza glabra inhibits lipopolysaccharide-interferon-gamma inflammation by improving
antioxidant conditions and regulating inducible nitric oxide synthase expression. Molecules. 2011; 16(7):
-34. doi: 10.3390/molecules16075720. PMID: 21734629.
Li C, Eom T, Jeong Y. Glycyrrhiza glabra L. Extract Inhibits LPS-Induced Inflammation in RAW
Macrophages. Journal of nutritional science and vitaminology. 2015; 61(5): 375-81. doi:
3177/jnsv.61.375. PMID: 26639845.
Brush J, Mendenhall E, Guggenheim A, Chan T, Connelly E, Soumyanath A, et al. The effect of Echinacea
purpurea, Astragalus membranaceus and Glycyrrhiza glabra on CD69 expression and immune cell
activation in humans. Phytotherapy research. 2006; 20(8): 687-95. PMID: 16807880.
Avicenna A. Canon of Medicine. Beirut: Dar ehya toras al-arabi; 2005: 16.
Jorjani SI. zakhireh Kharazmshahi. 1 ed. Qom: Ehya’e tibbe tabiee.
Aghili MH. Makhzan-al-Advia. In: Rahimi R, Shams-Ardekani MR, Farjadmand F, editors. Tehran, Iran:
Tehran University of Medical Sciences; 2009: 143,441,481.
A’azam khan Chashti M. The Grater Exir. 1 ed. Tehran: Research Institute for Islamic and Complementary
Medicine; 2008: 121.
Ibne-Nafis. A'shshamel fes senaa'tot tebbiah. 1 ed. Tehran: Research Institute for Islamic and
Complementary Medicine. 2000: 267.
Published
Issue
Section
License
Copyright (c) 2020 KNOWLEDGE KINGDOM PUBLISHING
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
